Pfizer and Moderna begin large late-phase clinical trials of their respective COVID-19 vaccines.
In a joint statement, the CEOs of nine pharmaceutical companies pledge to only submit a COVID-19 vaccine for approval once its safety and efficacy has been assessed This link will open in a new window during Phase 3 clinical trials, refusing to bow to political pressure to rush vaccine production.
Gavi announces a collaboration between AstraZeneca, the Serum Institute of India, and the Bill & Melinda Gates Foundation to share know-how and accelerate manufacturing This link will open in a new window of the AstraZeneca-Oxford vaccine.
GSK and Vir Biotechnology develop a monoclonal antibody for early treatment of COVID-19 patients This link will open in a new window, announcing the global expansion of a Phase 3 trial.
Gilead's antiviral treatment becomes the first and only FDA-approved This link will open in a new window COVID-19 treatment in the US.
The US grants emergency use authorization for Lilly's monoclonal antibody therapy This link will open in a new window.